Lung cancer is the deadliest cancer in the United States, and 80% of lung cancer deaths are linked to one risk factor: smoking. While lung cancer screenings are a critical part of prevention and treatment for the disease and 15 million Americans qualify for yearly screenings, over half those eligible for screenings are still actively smoking. Without standard smoking cessation measures in place, the benefits of the screenings have not been fully realized. New research published in JAMA Pulmonary Medicine , led by the University of Minnesota Medical School, examined how different combinations of behavioral treatment and medication affect tobacco cessation and, going forward, how they can be used to increase the benefits of lung cancer screenings.

https://www.miragenews.com/optimizing-lung-cancer-screening-with-tobacco-1071686/

#miragenews